Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026)
Emergent BioSolutions (EBS) reported Other Non-Current Assets of $11 million for Q2 2026, up 197.3% from $3.7 million a year earlier but down 15.4% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions posted Other Non-Current Assets of $14.2 million, down 24.9% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of -34.0% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $18.9 million in FY2024 and $58.2 million in FY2021 (-48.7%).
- Five-year quarterly Other Non-Current Assets spans a low of $500,000 in Q1 2024 and a high of $102.2 million in Q3 2021.
- Year over year, Other Non-Current Assets gained in five of the last six quarters, with growth averaging 221.1%.
- The high point for year-over-year Other Non-Current Assets in five years was Q1 2025 (growth of 640.0%); the low point was Q3 2022 (a decline of 60.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $13 million (Q1 2026), $14.2 million (Q4 2025) and $11.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.24 Bn | 1,099.82 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 614.68 Bn | 533.21 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.28 Bn | 476.39 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 368.01 Bn | 322.38 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.43 Bn | 262.42 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.67 Bn | 235.36 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.03 Bn | 191.43 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 190.92 Bn | 165.12 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Emergent BioSolutions | 318.89 Mn | -432.01 Mn | 137.20 Mn | 12.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.20 Mn |
| Mar 31, 2026 | 14.20 Mn |
| Dec 31, 2025 | 14.20 Mn |
| Sep 30, 2025 | 15.30 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 25.00 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 500,000.00 |
| Sep 30, 2022 | 40.80 Mn |
| Jun 30, 2022 | 51.30 Mn |
| Mar 31, 2022 | 57.10 Mn |
| Dec 31, 2021 | 58.20 Mn |
| Sep 30, 2021 | 102.20 Mn |
| Jun 30, 2021 | 109.90 Mn |
| Mar 31, 2021 | 111.40 Mn |
| Dec 31, 2020 | 113.40 Mn |
| Sep 30, 2020 | 106.40 Mn |
| Jun 30, 2020 | 101.60 Mn |
API Access
Emergent BioSolutions Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();